BlueLight Therapeutics Overview

  • Founded
  • 2008
Founded
  • Status
  • Private
  • Employees
  • 20
Employees
  • Latest Deal Type
  • Debt - PPP
  • Investors
  • 8

BlueLight Therapeutics General Information

Description

Developer of novel therapeutic molecules designed to measure structural changes of biomolecules in real-time. The company's platform is based on structural activity-based therapeutics to discover and develop molecules that induce functionally relevant structural changes in difficult-to-drug targets, as well as rapidly and inexpensively measure both protein structure and its functions, enabling pharmaceutical and biotechnology companies to gain significant insights into many human diseases and how different biomolecules function and respond to drug candidates.

Contact Information

Formerly Known As
Biodesy
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 170 Harbor Way
  • Suite 100 South
  • San Francisco, CA 94080
  • United States
+1 (650) 000-0000

BlueLight Therapeutics Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

BlueLight Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Debt - PPP 27-Apr-2020 000.00 Completed Generating Revenue
8. Grant 01-Jan-2019 00000 000.00 Completed Generating Revenue
7. Later Stage VC (Series C) 10-Sep-2018 0000 000.00 0000 Completed Generating Revenue
6. Later Stage VC (Series B) 07-Jan-2016 0000 000.00 000.00 Completed Generating Revenue
5. Early Stage VC (Series A) 17-Oct-2013 0000 000.00 000.00 Completed Startup
4. Grant 18-Mar-2013 00000 00000 Completed Startup
3. Grant 16-Nov-2011 00000 00000 Completed Startup
2. Angel (individual) 15-Dec-2009 $350K $821K Completed Startup
1. Angel (individual) 30-Nov-2008 $471K $471K Completed Startup
To view BlueLight Therapeutics’s complete valuation and funding history, request access »

BlueLight Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C 00,000,000 00.000000 00.00 00 00 00 00 00.000
Series B 0,000,000 00.000000 00.00 00.0 00.0 00 00.0 00.000
Series A 15,310,000 $0.000100 $0.08 $1 $1 1x $1 25.52%
To view BlueLight Therapeutics’s complete cap table history, request access »

BlueLight Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of novel therapeutic molecules designed to measure structural changes of biomolecules in real-time. The compan
Biotechnology
San Francisco, CA
20 As of 2021
000.00
000000000 - 000.00

00000000

on ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit i
0000 000000000
Nantes, France
00 As of 0000
00.000
0000000000 0 00.000

0000000

at. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla par
0000 000000000
South San Francisco, CA
000 As of 0000
00000
000000 - 000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BlueLight Therapeutics Competitors (13)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
InFlectis BioScience Venture Capital-Backed Nantes, France 00 00.000 0000000000 0 00.000
0000000 Formerly VC-backed South San Francisco, CA 000 00000 000000 - 000 00000
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
0000000 Venture Capital-Backed Framingham, MA 00 000.00 0000000000 000.00
000000000000000 Formerly VC-backed San Jose, CA 000.00 000000&0 000.00
You’re viewing 5 of 13 competitors. Get the full list »

BlueLight Therapeutics Executive Team (13)

Name Title Board Seat Contact Info
Ariel Notcovich Ph.D Chief Executive Officer & Board Member
Mark Gallop Ph.D Chief Scientific Officer & Board Member
Mira Chaurushiya Ph.D CBO & Board Observer
Michelle Kim-Danely Strategy and Business Development Leader
Lou Dietz Vice President, Engineering
You’re viewing 5 of 13 executive team members. Get the full list »

BlueLight Therapeutics Board Members (11)

Name Representing Role Since
Andrew Schwab 5AM Ventures Board Member 000 0000
Ariel Notcovich Ph.D BlueLight Therapeutics Chief Executive Officer & Board Member 000 0000
Joseph Victor Self Executive Chairman 000 0000
Mark Gallop Ph.D BlueLight Therapeutics Chief Scientific Officer & Board Member 000 0000
Mira Chaurushiya Ph.D BlueLight Therapeutics CBO & Board Observer 000 0000
You’re viewing 5 of 11 board members. Get the full list »

BlueLight Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BlueLight Therapeutics Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institutes of Health Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
Alexandria Venture Investments Corporate Venture Capital Minority 000 0000 000000 0
Columbia Technology Ventures University Minority 000 0000 000000 0
5AM Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »